News | July 28, 2023
Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Marks the World Head & Neck Cancer Day at the OCTF Conference
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Aurobindo will respond to the US FDA within the stipulated timelines
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
This product would be manufactured at Lupin's Nagpur facility in India
If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of HER2-positive advanced gastric or GEJ cancer in tumors expressing PD-L1 (CPS ?1) in the EU
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
Subscribe To Our Newsletter & Stay Updated
